Agenus (AGEN) Free Cash Flow (2010 - 2026)
Agenus' (AGEN) quarterly Free Cash Flow came in at -$35.9 million in Q1 2026, down 40.3% year-on-year from -$60.2 million in Q1 2025, and down 116.33% quarter-over-quarter from -$16.6 million in Q4 2025.
Agenus (AGEN) Free Cash Flow (2010 - 2026) Analysis & Trends
Agenus' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$35.9 million for Q1 2026.
- On a quarterly basis, Free Cash Flow fell 40.3% year-over-year to -$35.9 million in Q1 2026; TTM through Mar 2026 was -$87.5 million, a 40.17% increase from a year earlier, with the FY2025 full-year figure at -$77.2 million, up 51.41% from the prior year.
- Free Cash Flow retreated to -$35.9 million in Q1 2026 per AGEN's latest filing, from -$16.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$14.7 million in Q3 2025 and bottomed at -$68.7 million in Q3 2023.
- The 5-year median for Free Cash Flow is -$38.6 million (2024), against an average of -$40.4 million.
- Across the five-year window, Free Cash Flow plunged 127.56% in 2023 and jumped 72.35% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$43.4 million in 2022, then climbed by 6.33% to -$40.6 million in 2023, then rose by 29.29% to -$28.7 million in 2024, then soared by 42.15% to -$16.6 million in 2025, then tumbled by 116.33% to -$35.9 million in 2026.
- Per Business Quant, the three latest AGEN Free Cash Flow figures stand at -$35.9 million (Q1 2026), -$16.6 million (Q4 2025), and -$14.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | -35.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.95 Mn |
| Mar 31, 2026 | -35.95 Mn |
| Dec 31, 2025 | -16.62 Mn |
| Dec 31, 2025 | -16.62 Mn |
| Sep 30, 2025 | -14.74 Mn |
| Sep 30, 2025 | -14.74 Mn |
| Jun 30, 2025 | -20.22 Mn |
| Jun 30, 2025 | -20.22 Mn |
| Mar 31, 2025 | -25.62 Mn |
| Mar 31, 2025 | -25.62 Mn |
| Dec 31, 2024 | -28.73 Mn |
| Dec 31, 2024 | -28.73 Mn |
| Sep 30, 2024 | -53.30 Mn |
| Sep 30, 2024 | -53.30 Mn |
| Jun 30, 2024 | -38.64 Mn |
| Jun 30, 2024 | -38.64 Mn |
| Mar 31, 2024 | -38.23 Mn |
| Mar 31, 2024 | -38.23 Mn |
| Dec 31, 2023 | -40.63 Mn |
| Dec 31, 2023 | -40.63 Mn |